TOSO promotes β-cell proliferation and protects from apoptosis

G Dharmadhikari1, M Mühle, F T Schulthess

  • 1Centre for Biomolecular Interactions Bremen, University of Bremen, Germany.

Molecular Metabolism
|September 12, 2013
PubMed

Insights

Fas apoptotic inhibitory protein (TOSO) blocks pancreatic beta-cell death and promotes proliferation, offering a potential therapeutic target for diabetes by regulating beta-cell survival and turnover.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Diabetes Research

Background:

  • Decreased beta-cell mass is central to diabetes pathophysiology, driven by increased apoptosis.
  • Restoring beta-cell mass and function is a key therapeutic goal for managing diabetes.

Purpose of the Study:

  • To investigate the role of Fas apoptotic inhibitory protein (Faim/TOSO) in regulating beta-cell apoptosis and proliferation.
  • To explore TOSO as a potential therapeutic target for diabetes.

Main Methods:

  • Investigated the effect of modulating the Fas pathway using Faim/TOSO in human islets.
  • Assessed beta-cell apoptosis, proliferation, and TOSO expression in relation to Type 2 Diabetes Mellitus (T2DM).

Main Results:

  • Inhibition of the Fas pathway via Faim/TOSO blocked beta-cell apoptosis and enhanced proliferation in human islets.
  • TOSO expression was detected in pancreatic beta-cells and found to be downregulated in T2DM.
  • TOSO expression correlated with beta-cell turnover, with induction under conditions of improved survival and downregulation leading to apoptosis.

Conclusions:

  • Faim/TOSO acts as a crucial regulator of beta-cell turnover, shifting the balance from apoptosis towards proliferation.
  • TOSO represents a promising target for therapeutic strategies aimed at preserving beta-cell mass in diabetes.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...